Sensitive multiplex PCR assay to differentiate Lyme spirochetes and emerging pathogens Anaplasma phagocytophilum and Babesia microti

BMC Microbiology

Volumn 13, Issue 1, 2013, Pages

  Chan, Kamfai ^a   Marras, Salvatore Ae ^a,b   Parveen, Nikhat ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Anaplasma phagocytophilum; Anaplasmosis; Babesia microti; Babesiosis; Borrelia burgdorferi; Lyme disease; Molecular beacons; Multiplex assay; Real time PCR; Tick borne emerging pathogens

Indexed keywords

ALPHA ACTIN; BACTERIAL DNA; GENOMIC DNA; RECA PROTEIN;

AMPLICON; ANAPLASMA PHAGOCYTOPHILUM; ARTICLE; BABESIA MICROTI; BACTERIUM DETECTION; BLOOD ANALYSIS; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; CONTROLLED STUDY; DENATURATION; EMBRYO; HUMAN; HUMAN CELL; LYME DISEASE; MOLECULAR BEACON; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PATHOGENESIS; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS;

ANAPLASMA PHAGOCYTOPHILUM; BABESIA; BABESIA MICROTI; BORRELIA BURGDORFERI; IXODIDA; SPIROCHAETALES;

ANAPLASMA PHAGOCYTOPHILUM; BABESIA MICROTI; BABESIOSIS; BORRELIA; DNA PRIMERS; EHRLICHIOSIS; EUROPE; HUMANS; LYME DISEASE; MOLECULAR DIAGNOSTIC TECHNIQUES; MULTIPLEX POLYMERASE CHAIN REACTION; OLIGONUCLEOTIDE PROBES; REAL-TIME POLYMERASE CHAIN REACTION; UNITED STATES;

EID: 84890472228     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-13-295     Document Type: Article

References (89)

1. Ticks and tick-borne diseases: a One Health perspective. Dantas-Torres F, Chomel BB, Otranto D, Trends Parasitol 2012 28 10 437 446 10.1016/j.pt.2012.07. 003 22902521
2. A clear and present danger: tick-borne diseases in Europe. Heyman P, Cochez C, Hofhuis A, van der Giessen J, Sprong H, Porter SR, Losson B, Saegerman C, Donoso-Mantke O, Niedrig M, et al. Expert Rev Anti Infect Ther 2010 8 1 33 50 10.1586/eri.09.118 20014900
3. Questing ticks in Suburban Forest are infected by at least six tick-borne pathogens. Reis C, Cote M, Paul RE, Bonnet S, Vector Borne Zoonotic Dis 2010 11 7 07 916
4. Co-circulation of emerging tick-borne pathogens in Middle Germany. Hildebrandt A, Fritzsch J, Franke J, Sachse S, Dorn W, Straube E, Vector Borne Zoonotic Dis 2011 11 5 533 537 10.1089/vbz.2010.0048 20846013
5. Established and emerging pathogens in Ixodes ricinus ticks collected from birds on a conservation island in the Baltic Sea. Franke J, Meier F, Moldenhauer A, Straube E, Dorn W, Hildebrandt A, Med Vet Entomol 2010 24 4 425 432 10.1111/j.1365-2915.2010.00905.x 20868431
6. Assessment of polymicrobial infections in ticks in New York state. Tokarz R, Jain K, Bennett A, Briese T, Lipkin WI, Vector Borne Zoonotic Dis 2010 10 3 217 221 10.1089/vbz.2009.0036 19725770
7. Potential effects of mixed infections in ticks on transmission dynamics of pathogens: comparative analysis of published records. Ginsberg HS, Exp Appl Acarol 2008 46 1-4 29 41 18648996
8. Human Babesia microti incidence and Ixodes scapularis distribution, Rhode Island, 1998-2004. Rodgers SE, Mather TN, Emerg Infect Dis 2007 13 4 633 635 10.3201/eid1304.061035 17553286 (Pubitemid 46525118)
9. Epidemiology and impact of coinfections acquired from Ixodes ticks. Belongia EA, Vector Borne Zoonotic Dis 2002 2 4 265 273 10.1089/ 153036602321653851 12804168
10. Human babesiosis. Vannier E, Gewurz BE, Krause PJ, Infect Dis Clin North Am 2008 22 3 469 488 viii-ix 10.1016/j.idc.2008.03.010 18755385
11. Seasonal prevalence of serum antibodies to whole cell and recombinant antigens of Borrelia burgdorferi and Anaplasma phagocytophilum in white-tailed deer in Connecticut. Magnarelli LA, Williams SC, Fikrig E, J Wildl Dis 2010 46 3 781 790 10.7589/0090-3558-46.3.781 20688684
12. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Telford SR 3rd, Dawson JE, Katavolos P, Warner CK, Kolbert CP, Persing DH, Proc Natl Acad Sci USA 1996 93 12 6209 6214 10.1073/pnas.93.12. 6209 8650245 (Pubitemid 26190829)
13. Comparison of the reservoir competence of medium-sized mammals and Peromyscus leucopus for Anaplasma phagocytophilum in Connecticut. Levin ML, Nicholson WL, Massung RF, Sumner JW, Fish D, Vector Borne Zoonotic Dis 2002 2 3 125 136 10.1089/15303660260613693 12737542
14. Anaplasma phagocytophilum and Ehrlichia chaffeensis: subversive manipulators of host cells. Rikihisa Y, Nat Rev Microbiol 2010 8 5 328 339 10.1038/nrmicro2318 20372158
15. Clinical presentation of 26 Anaplasma phagocytophilum-seropositive dogs residing in an endemic area. Mazepa AW, Kidd LB, Young KM, Trepanier LA, J Am Anim Hosp Assoc 2010 46 6 405 412 21041333
16. Enzootic Babesia microti in Maine. Goethert HK, Lubelcyzk C, LaCombe E, Holman M, Rand P, Smith RP Jr, Telford SR 3rd, J Parasitol 2003 89 5 1069 1071 10.1645/GE-3149RN 14627162 (Pubitemid 37443252)
17. Increasing health burden of human babesiosis in endemic sites. Krause PJ, McKay K, Gadbaw J, Christianson D, Closter L, Lepore T, Telford SR 3rd, Sikand V, Ryan R, Persing D, et al. Am J Trop Med Hyg 2003 68 4 431 436 12875292 (Pubitemid 38230643)
18. Endemic babesiosis in another eastern state: New Jersey. Herwaldt BL, McGovern PC, Gerwel MP, Easton RM, MacGregor RR, Emerg Infect Dis 2003 9 2 184 188 10.3201/eid0902.020271 12603988 (Pubitemid 36231788)
19. Relationship between tick bites and the seroprevalence of Babesia microti and Anaplasma phagocytophila (previously Ehrlichia sp.) in blood donors. Leiby DA, Chung AP, Cable RG, Trouern-Trend J, McCullough J, Homer MJ, Reynolds LD, Houghton RL, Lodes MJ, Persing DH, Transfusion 2002 42 12 1585 1591 10.1046/j.1537-2995.2002.00251.x 12473139
20. Coinfection with Babesia microti and Borrelia burgdorferi in a western Wisconsin resident. Sweeney CJ, Ghassemi M, Agger WA, Persing DH, Mayo Clin Proc 1998 73 4 338 341 10.1016/S0025-6196(11)63699-9 9559037 (Pubitemid 28169685)
21. Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota. Mitchell PD, Reed KD, Hofkes JM, J Clin Microbiol 1996 34 3 724 727 8904446 (Pubitemid 26065807)
22. Performance of a commercially available in-clinic ELISA for the detection of antibodies against Anaplasma phagocytophilum, Ehrlichia canis, and Borrelia burgdorferi and Dirofilaria immitis antigen in dogs. Chandrashekar R, Mainville CA, Beall MJ, O'Connor T, Eberts MD, Alleman AR, Gaunt SD, Breitschwerdt EB, Am J Vet Res 2010 71 12 1443 1450 10.2460/ajvr.71.12.1443 21117995
23. Anaplasmosis in dogs: the relation of haematological, biochemical and clinical alterations to antibody titre and PCR confirmed infection. Ravnik U, Tozon N, Smrdel KS, Zupanc TA, Vet Microbiol 2011 149 1-2 172 176 21112165
24. Transfusion-associated babesiosis in the United States: a description of cases. Herwaldt BL, Linden JV, Bosserman E, Young C, Olkowska D, Wilson M, Ann Intern Med 2011 155 8 509 519 10.7326/0003-4819-155-8-201110180-00362 21893613
25. Severe babesiosis in Long Island: review of 34 cases and their complications. Hatcher JC, Greenberg PD, Antique J, Jimenez-Lucho VE, Clin Infect Dis 2001 32 8 1117 1125 10.1086/319742 11283800 (Pubitemid 32381117)
26. Summary of notifiable diseases - - United States, 2009. MMWR Morb Mortal Wkly Rep 2011 58 53 1 100 21566560
27. Differences and similarities between culture-confirmed human granulocytic anaplasmosis and early Lyme disease. Wormser GP, Aguero-Rosenfeld ME, Cox ME, Nowakowski J, Nadelman RB, Holmgren D, McKenna D, Bittker S, Zentmaier L, Cooper D, et al. J Clin Microbiol 2013 51 3 954 958 10.1128/JCM.02929-12 23303504
28. Serological survey in persons occupationally exposed to tick-borne pathogens in cases of co-infections with Borrelia burgdorferi, Anaplasma phagocytophilum, Bartonella spp. and Babesia microti. Chmielewska-Badora J, Moniuszko A, Zukiewicz-Sobczak W, Zwolinski J, Piatek J, Pancewicz S, Ann Agric Environ Med 2012 19 2 271 274 22742800
29. Infections and coinfections of questing Ixodes ricinus ticks by emerging zoonotic pathogens in Western Switzerland. Lommano E, Bertaiola L, Dupasquier C, Gern L, Appl Environ Microbiol 2012 78 13 4606 4612 10.1128/AEM.07961-11 22522688
30. Prevalence of Lyme disease agents and several emerging pathogens in questing ticks from the German Baltic coast. Franke J, Hildebrandt A, Meier F, Straube E, Dorn W, J Med Entomol 2011 48 2 441 444 10.1603/ME10182 21485387
31. Experimental transmission of Ehrlichia chaffeensis (Rickettsiales: Ehrlichieae) among white-tailed deer by Amblyomma americanum (Acari: Ixodidae). Ewing SA, Dawson JE, Kocan AA, Barker RW, Warner CK, Panciera RJ, Fox JC, Kocan KM, Blouin EF, J Med Entomol 1995 32 3 368 374 7616529
32. Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. Aguero-Rosenfeld ME, Donnarumma L, Zentmaier L, Jacob J, Frey M, Noto R, Carbonaro CA, Wormser GP, J Med Entomol 2002 40 7 2612 2615 (Pubitemid 34752170)
33. Role of experience and context in learning to diagnose Lyme disease. Bakken LL, J Contin Educ Health Prof 2002 22 3 131 141 10.1002/chp.1340220302 12227235
34. Human granulocytic anaplasmosis. Bakken JS, Dumler S, Infect Dis Clin North Am 2008 22 3 433 448 viii 10.1016/j.idc.2008.03.011 18755383
35. Diagnosis and management of Lyme disease. Wright WF, Riedel DJ, Talwani R, Gilliam BL, Am Fam Physician 2012 85 11 1086 1093 22962880
36. Utility of a commercial immunoblot kit (BAG-Borrelia blot) in the diagnosis of the preliminary stages of Lyme disease. Hernandez-Novoa B, Orduna A, Bratos MA, Eiros JM, Fernandez JM, Gutierrez MP, Alonso PA, Mantecon MA, Almaraz A, Oteo JA, et al. Diagn Microbiol Infect Dis 2003 47 1 321 329 10.1016/S0732-8893(03)00111-1 12967745 (Pubitemid 37101164)
37. Lyme borreliosis in Sweden-diagnostic performance of five commercial Borrelia serology kits using sera from well-defined patient groups. Ekerfelt C, Ernerudh J, Forsberg P, Jonsson AL, Vrethem M, Arlehag L, Forsum U, APMIS 2004 112 1 74 78 10.1111/j.1600-0463.2004.apm1120112.x 14961978 (Pubitemid 38297170)
38. Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease. Mogilyansky E, Loa CC, Adelson ME, Mordechai E, Tilton RC, Clin Diagn Lab Immunol 2004 11 5 924 929 15358654 (Pubitemid 39280600)
39. Diagnosis of lyme borreliosis. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP, Clin Microbiol Rev 2005 18 3 484 509 10.1128/CMR.18.3.484-509.2005 16020686 (Pubitemid 40995113)
40. Microbiological and serological diagnosis of Lyme borreliosis. Wilske B, Fingerle V, Schulte-Spechtel U, FEMS Immunol Med Microbiol 2007 49 1 13 21 10.1111/j.1574-695X.2006.00139.x 17266710 (Pubitemid 46160581)
41. Development of real time PCR to detect Toxoplasma gondii and Borrelia burgdorferi infections in postal samples. Joss AW, Evans R, Mavin S, Chatterton J, Ho-Yen DO, J Clin Pathol 2008 61 2 221 224 17496189 (Pubitemid 351218885)
42. Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti. Leiby DA, Clin Microbiol Rev 2011 24 1 14 28 10.1128/CMR.00022-10 21233506
43. Transmission of Babesia microti in Minnesota through four blood donations from the same donor over a 6-month period. Herwaldt BL, Neitzel DF, Gorlin JB, Jensen KA, Perry EH, Peglow WR, Slemenda SB, Won KY, Nace EK, Pieniazek NJ, et al. Transfusion 2002 42 9 1154 1158 10.1046/j.1537-2995.2002.00189.x 12430672
44. Vertical transmission of Babesia microti, United States. Joseph JT, Purtill K, Wong SJ, Munoz J, Teal A, Madison-Antenucci S, Horowitz HW, Aguero-Rosenfeld ME, Moore JM, Abramowsky C, et al. Emerg Infect Dis 2012 18 8 1318 1321 22840424
45. Babesiosis diagnosis and treatment. Krause PJ, Vector Borne Zoonotic Dis 2003 3 1 45 51 10.1089/153036603765627451 12804380
46. Detection of Babesia microti by polymerase chain reaction. Persing DH, Mathiesen D, Marshall WF, Telford SR, Spielman A, Thomford JW, Conrad PA, J Clin Microbiol 1992 30 8 2097 2103 1500517
47. Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis. Thomas RJ, Dumler JS, Carlyon JA, Expert Rev Anti Infect Ther 2009 7 6 709 722 10.1586/eri.09.44 19681699
48. Clinical diagnosis and treatment of human granulocytotropic anaplasmosis. Bakken JS, Dumler JS, Ann N Y Acad Sci 2006 1078 236 247 10.1196/annals.1374. 042 17114714 (Pubitemid 46001340)
49. Human granulocytic anaplasmosis and Anaplasma phagocytophilum. Dumler JS, Choi KS, Garcia-Garcia JC, Barat NS, Scorpio DG, Garyu JW, Grab DJ, Bakken JS, Emerg Infect Dis 2005 11 12 1828 1834 10.3201/eid1112.050898 16485466 (Pubitemid 43361465)
50. Antisense technologies. Improvement through novel chemical modifications. Kurreck J, Eur J Biochem 2003 270 8 1628 1644 10.1046/j.1432-1033.2003.03555.x 12694176 (Pubitemid 36532522)
51. Use of sloppy molecular beacon probes for identification of mycobacterial species. El-Hajj HH, Marras SA, Tyagi S, Shashkina E, Kamboj M, Kiehn TE, Glickman MS, Kramer FR, Alland D, J Clin Microbiol 2009 47 4 1190 1198 10.1128/JCM.02043-08 19171684
52. Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings. Banada PP, Sivasubramani SK, Blakemore R, Boehme C, Perkins MD, Fennelly K, Alland D, J Clin Microbiol 2010 48 10 3551 3557 10.1128/JCM.01053-10 20720033
53. A new real-time PCR assay for improved detection of the parasite Babesia microti. Teal AE, Habura A, Ennis J, Keithly JS, Madison-Antenucci S, J Clin Microbiol 2012 50 3 903 908 10.1128/JCM.05848-11 22170915
54. Efficiencies of fluorescence resonance energy transfer and contact-mediated quenching in oligonucleotide probes. Marras SA, Kramer FR, Tyagi S, Nucleic Acids Res 2002 30 21 122 10.1093/nar/gnf121 12409481
55. Multicolor molecular beacons for allele discrimination. Tyagi S, Bratu DP, Kramer FR, Nat Biotechnol 1998 16 1 49 53 10.1038/nbt0198-49 9447593 (Pubitemid 28035948)
56. Multiplex detection of single-nucleotide variations using molecular beacons. Marras SA, Kramer FR, Tyagi S, Genet Anal 1999 14 5-6 151 156 10084107 (Pubitemid 29095372)
57. Using molecular beacons to detect single-nucleotide polymorphisms with real-time PCR. Mhlanga MM, Malmberg L, Methods 2001 25 4 463 471 10.1006/meth.2001.1269 11846616 (Pubitemid 34164019)
58. Thermodynamic basis of the enhanced specificity of structured DNA probes. Bonnet G, Tyagi S, Libchaber A, Kramer FR, Proc Natl Acad Sci USA 1999 96 11 6171 6176 10.1073/pnas.96.11.6171 10339560 (Pubitemid 29256638)
59. Short PNA molecular beacons for real-time PCR allelic discrimination of single nucleotide polymorphisms. Petersen K, Vogel U, Rockenbauer E, Nielsen KV, Kolvraa S, Bolund L, Nexo B, Mol Cell Probes 2004 18 2 117 122 10.1016/j.mcp.2003.10.003 15051121 (Pubitemid 38402224)
60. Homogeneous scoring of single-nucleotide polymorphisms: comparison of the 5'-nuclease TaqMan assay and Molecular Beacon probes. Tapp I, Malmberg L, Rennel E, Wik M, Syvanen AC, Biotechniques 2000 28 4 732 738 10769752 (Pubitemid 30198610)
61. Detection and quantification of Lyme spirochetes using sensitive and specific molecular beacon probes. Saidac DS, Marras SA, Parveen N, BMC Microbiol 2009 9 1 43 52 10.1186/1471-2180-9-43 19239692
62. Identification of a candidate glycosaminoglycan-binding adhesin of the Lyme disease spirochete Borrelia burgdorferi. Parveen N, Leong JM, Mol Microbiol 2000 35 5 1220 1234 10.1046/j.1365-2958.2000.01792.x 10712702 (Pubitemid 30137790)
63. Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. Morrison TB, Ma Y, Weis JH, Weis JJ, J Clin Microbiol 1999 37 4 987 992 10074514 (Pubitemid 29140602)
64. Design and optimization of molecular beacon real-time polymerase chain reaction assays. Vet JA, Marras SA, Methods Mol Biol 2005 288 273 290 15333910
65. Sequencing of the smallest Apicomplexan genome from the human pathogen Babesia microti. Cornillot E, Hadj-Kaddour K, Dassouli A, Noel B, Ranwez V, Vacherie B, Augagneur Y, Bres V, Duclos A, Randazzo S, et al. Nucleic Acids Res 2012 40 18 9102 9114 10.1093/nar/gks700 22833609
66. Anaplasma phagocytophilum APH-1387 is expressed throughout bacterial intracellular development and localizes to the pathogen-occupied vacuolar membrane. Huang B, Troese MJ, Ye S, Sims JT, Galloway NL, Borjesson DL, Carlyon JA, Infect Immun 2010 78 5 1864 1873 10.1128/IAI.01418-09 20212090
67. Tired of Lyme borreliosis. Lyme borreliosis in the Netherlands. Coumou J, van der Poll T, Speelman P, Hovius JW, Neth J Med 2011 69 3 101 111 21444934
68. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, Kristoferitsch W, O'Connell S, Ornstein K, Strle F, et al. Clin Microbiol Infect 2011 17 1 69 79 10.1111/j.1469-0691.2010.03175.x 20132258
69. Reports of nationally notifiable infectious diseases - -United States, 2011. Adams DA, Gallagher KM, Jajosky RA, Kriseman J, Sharp P, Anderson WJ, Aranas AE, Mayes M, Wodajo MS, Onweh DH, Abellera JP, MMWR Morb Mortal Wkly Rep 2013 60 53 1 117 23820934
70. Babesia: a world emerging. Schnittger L, Rodriguez AE, Florin-Christensen M, Morrison DA, Infect Genet Evol 2012 12 8 1788 1809 10.1016/j.meegid.2012.07. 004 22871652
71. Seroprevalence of Babesia microti in blood donors from Babesia-endemic areas of the northeastern United States: 2000 through 2007. Johnson ST, Cable RG, Tonnetti L, Spencer B, Rios J, Leiby DA, Transfusion 2009 49 12 2574 2582 10.1111/j.1537-2995.2009.02430.x 19821951
72. Transfusion-transmitted Babesia microti identified through hemovigilance. Tonnetti L, Eder AF, Dy B, Kennedy J, Pisciotto P, Benjamin RJ, Leiby DA, Transfusion 2009 49 12 2557 2563 10.1111/j.1537-2995.2009.02317.x 19624607
73. Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program. Young C, Chawla A, Berardi V, Padbury J, Skowron G, Krause PJ, Transfusion 2012 52 7 1523 1529 10.1111/j.1537-2995.2012.03612.x 22452654
74. Transfusion-transmitted babesiosis: achieving successful mitigation while balancing cost and donor loss. Cushing M, Shaz B, Transfusion 2012 52 7 1404 1407 10.1111/j.1537-2995.2012.03746.x 22780893
75. Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists. Meng W, Yamazaki T, Nishida Y, Hanagata N, BMC Biotechnol 2011 11 88 10.1186/1472-6750-11-88 21943407
76. Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides. Mutwiri GK, Nichani AK, Babiuk S, Babiuk LA, J Control Release 2004 97 1 1 17 10.1016/j.jconrel.2004.02.022 15147800 (Pubitemid 38624505)
77. Evaluation of a rapid test for the diagnosis of pneumococcal pneumonia. Monno R, Fumarola L, Mercadante G, Tzakis G, Battista M, Miragliotta G, J Microbiol Methods 2013 92 2 127 131 10.1016/j.mimet.2012.11.011 23201168
78. Detection of tick-borne pathogens by MassTag polymerase chain reaction. Tokarz R, Kapoor V, Samuel JE, Bouyer DH, Briese T, Lipkin WI, Vector Borne Zoonotic Dis 2009 9 2 147 152 10.1089/vbz.2008.0088 18800864
79. Quantitation of cell-associated borrelial DNA in the blood of Lyme disease patients with erythema migrans. Liveris D, Schwartz I, McKenna D, Nowakowski J, Nadelman RB, DeMarco J, Iyer R, Cox ME, Holmgren D, Wormser GP, Eur J Clin Microbiol Infect Dis 2012 31 5 791 795 10.1007/s10096-011-1376-x 21842448
80. Direct molecular detection and genotyping of Borrelia burgdorferi from whole blood of patients with early Lyme disease. Eshoo MW, Crowder CC, Rebman AW, Rounds MA, Matthews HE, Picuri JM, Soloski MJ, Ecker DJ, Schutzer SE, Aucott JN, PLoS One 2012 7 5 36825 10.1371/journal.pone.0036825 22590620
81. Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity. Horowitz HW, Aguero-Rosenfeld ME, Holmgren D, McKenna D, Schwartz I, Cox ME, Wormser GP, Clin Infect Dis 2013 56 1 93 99 10.1093/cid/cis852 23042964
82. Multiplex MassTag-PCR for respiratory pathogens in pediatric nasopharyngeal washes negative by conventional diagnostic testing shows a high prevalence of viruses belonging to a newly recognized rhinovirus clade. Dominguez SR, Briese T, Palacios G, Hui J, Villari J, Kapoor V, Tokarz R, Glode MP, Anderson MS, Robinson CC, et al. J Clin Virol 2008 43 2 219 222 10.1016/j.jcv.2008.06.007 18674964
83. Evaluation of real-time PCR targeting hbb gene for Borrelia species identification. Ferdin J, Cerar T, Strle F, Ruzic-Sabljic E, J Microbiol Methods 2010 82 2 115 119 10.1016/j.mimet.2010.04.009 20451566
84. Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability. Iyer R, Mukherjee P, Wang K, Simons J, Wormser GP, Schwartz I, J Clin Microbiol 2013 51 3 857 862 10.1128/JCM.02785-12 23269733
85. Improving the yield of blood cultures from patients with early Lyme disease. Liveris D, Schwartz I, Bittker S, Cooper D, Iyer R, Cox ME, Wormser GP, J Clin Microbiol 2011 49 6 2166 2168 10.1128/JCM.00350-11 21490189
86. Comparison of five diagnostic modalities for direct detection of Borrelia burgdorferi in patients with early Lyme disease. Liveris D, Schwartz I, McKenna D, Nowakowski J, Nadelman R, Demarco J, Iyer R, Bittker S, Cooper D, Holmgren D, et al. Diagn Microbiol Infect Dis 2012 73 3 243 245 10.1016/j.diagmicrobio. 2012.03.026 22571973
87. Prevalence and genetic characterization of Powassan virus strains infecting Ixodes scapularis in Connecticut. Anderson JF, Armstrong PM, Am J Trop Med Hyg 2012 87 4 754 759 10.4269/ajtmh.2012.12-0294 22890037
88. Powassan virus infection: case series and literature review from a single institution. Raval M, Singhal M, Guerrero D, Alonto A, BMC Res Notes 2012 5 594 10.1186/1756-0500-5-594 23111001
89. Tick-borne encephalitis virus and louping-Ill virus may co-circulate in Southern Norway. Ytrehus B, Vainio K, Dudman SG, Gilray J, Willoughby K, Vector Borne Zoonotic Dis 2013 13 10 762 768 10.1089/vbz.2012.1023 23808981